AP1S1 Inhibitors are a class of chemical compounds specifically designed to target and inhibit the AP1S1 protein, which is a key component of the adaptor protein complex 1 (AP-1). AP-1 is involved in the transport of membrane proteins between the trans-Golgi network (TGN) and endosomes, playing a crucial role in the sorting and trafficking of various cellular cargo. AP1S1, the small subunit of the AP-1 complex, is essential for the proper assembly and function of the entire complex, mediating the interaction between the AP-1 complex and clathrin-coated vesicles. AP1S1 Inhibitors function by binding to critical regions of the AP1S1 protein, such as the binding sites that interact with clathrin or other adaptor proteins. This binding interferes with the assembly and function of the AP-1 complex, thereby disrupting the normal vesicular trafficking pathways within the cell.
The design and efficacy of AP1S1 Inhibitors depend heavily on their chemical properties and molecular structure. These inhibitors are often engineered to mimic the natural ligands or interacting partners of AP1S1, allowing them to competitively bind to the protein and block its interaction with other components of the AP-1 complex or with cargo proteins. The inhibitors may include specific functional groups that enhance binding affinity, such as hydrophobic moieties that interact with non-polar regions of the AP1S1 protein or polar groups that form hydrogen bonds with key residues in the protein's binding interface. Additionally, the inhibitors are designed to be stable and soluble in the cellular environment, ensuring they can effectively reach and inhibit AP1S1 in its native context. The kinetics of binding, including the rates of association and dissociation, are critical factors that determine the potency and duration of the inhibition. By studying the interactions between AP1S1 Inhibitors and their target protein, researchers can gain valuable insights into the mechanisms of vesicular trafficking and the broader role of the AP-1 complex in maintaining cellular organization and function. Understanding these interactions is essential for elucidating how disruptions in AP1S1 activity can impact cellular processes related to protein sorting and membrane trafficking.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin, a polyphenolic compound from turmeric, has been shown to modulate various signaling pathways, including those associated with protein trafficking. It might potentially impact the expression of AP-1 complex subunit sigma-1A by altering these pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol, a compound found in grapes, has been shown to modulate various cellular pathways. Its potential to inhibit the expression of AP-1 complex subunit sigma-1A may arise from its general effects on protein expression and trafficking. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein, an isoflavone, has been reported to modulate protein synthesis and trafficking. It may influence the expression of AP-1 complex subunit sigma-1A through these mechanisms. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a potent PI3K inhibitor. By inhibiting PI3K, it may indirectly affect various cellular pathways, potentially influencing the expression of AP-1 complex subunit sigma-1A. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is another PI3K inhibitor. Similar to Wortmannin, it might have an indirect effect on the expression of AP-1 complex subunit sigma-1A by modulating related pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is an mTOR inhibitor. By inhibiting mTOR, it could influence various cellular processes, potentially impacting the expression of AP-1 complex subunit sigma-1A. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MAPK inhibitor. As MAPK pathways can be involved in protein expression and sorting, inhibiting this pathway might influence the expression of AP-1 complex subunit sigma-1A. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By targeting the p38 MAPK pathway, it might potentially modulate the expression of AP-1 complex subunit sigma-1A. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. Since the JNK pathway can be involved in cellular protein expression and trafficking, its inhibition might impact the expression of AP-1 complex subunit sigma-1A. | ||||||
Fisetin | 528-48-3 | sc-276440 sc-276440A sc-276440B sc-276440C sc-276440D | 50 mg 100 mg 500 mg 1 g 100 g | $51.00 $77.00 $102.00 $153.00 $2856.00 | 7 | |
Fisetin, a flavonoid, has been shown to influence cellular signaling pathways. Its potential effects on AP-1 complex subunit sigma-1A expression could arise from these influences. | ||||||